— Know what they know.
Not Investment Advice
Also trades as: VIMTALABS.NS (NSE) · $vol 2M

VIMTALABS.BO BSE

Vimta Labs Limited
1W: -2.3% 1M: -12.1% 3M: -0.5% YTD: +25.0% 1Y: -11.5% 3Y: +29.0% 5Y: +97.9%
₹590.00 ($6.13)
-12.90 (-2.14%)
 
BSE · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 32 · ₹26.4B mcap · 15M float · 0.141% daily turnover

Cash Flow Trends

Operating Cash Flow
$1.5B +56.8% ▲
5Y CAGR: +31.9%
Capital Expenditures
$997M -26.1% ▼
5Y CAGR: +24.7%
Free Cash Flow
$490M +210.7% ▲
5Y CAGR: +64.3%
Dividends Paid
$45M -0.4% ▼
Buybacks
$0 +0.0% ▲
Net Change in Cash
$490M +1946.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$557M$650M$410M$668M$775M
Depreciation & Amort.$233M$307M$342M$353M$438M
Stock-Based Comp.$29M$41M$16M$0$0
Change in Working Capital-$114M-$36M-$154M-$80M$162M
Other Non-Cash Items-$115M-$82M-$5M$8M$112M
Operating Cash Flow$591M$879M$609M$948M$1.5B
— Investing Activities —
Capital Expenditures-$298M-$478M-$763M-$795M-$998M
Acquisitions (Net)$0$0$0$99M$860K
Investment Purchases-$160K$0$0-$48M-$320M
Investment Sales-$260K$0$0$0$0
Other Investing-$80M-$94M$3M-$12M$0
Investing Cash Flow-$378M-$573M-$760M-$755M-$1.3B
— Financing Activities —
Net Debt Issuance-$114M-$57M$40M-$109M-$54M
Stock Repurchased$0$0$0$0$0
Dividends Paid-$44M-$44M-$44M-$44M-$45M
Other Financing-$8M-$9M-$15M-$13M$0
Financing Cash Flow-$166M-$110M-$19M-$167M-$98M
Net Change in Cash$46M$197M-$171M$24M$490M
Cash End of Period$108M$305M$134M$158M$651M
Free Cash Flow$203M$381M-$157M$158M$490M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms